Vertex Pharmaceuticals, Inc.

Vertex Pharmaceuticals, Inc.

Vertex Pharmaceuticals, Inc.

Overview
Date Founded

1989

Headquarters

50 NORTHERN AVE., BOSTON, MA, 02210

Type of Company

Public

Employees (Worldwide)

3,400

Industries

Pharmaceuticals
Biotechnology

Company Description

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Contact Data
Trying to get in touch with decision makers at Vertex Pharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Director, President & Chief Executive Officer

Executive Chairman

Executive Vice President & Chief Financial Officer

Chief Commercial Officer & Executive Vice President

Executive Vice President, Global Research & Chief Scientific Officer

Senior Vice President, Controller & Chief Accounting Officer

Chief Regulatory Officer

Senior Vice President & Chief Communications Officer

Chief Medical Officer & Executive Vice President-Medical Affairs

Board of Directors

Executive Chairman at Vertex Pharmaceuticals, Inc.

Co-Founder at Glympse Bio, Inc.

Former President, Chief Executive Officer & Director at International AIDS Vaccine Initiative

Provost at Harvard University

Co-Founder at Allego, Inc.

Chief Acquisition Officer at Carney Technology Acquisition Corp. II

Director, President & Chief Executive Officer at Vertex Pharmaceuticals, Inc.

Former Senior Vice President, Finance & Chief Financial Officer at Hospira, Inc.

Special Advisor at Brighton Park Capital LLC

Chief Executive Officer & Director at Bam Bam Resources Corp.

Paths to Vertex Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Vertex Pharmaceuticals, Inc.
Owners & Shareholders
Details Hidden

AB is a research-driven investment adviser that is global in scope and client-centered in its approach. Its global team of research professionals, whose disciplines include economic, fundamental equity, fixed income and quantitative research gives them a competitive advantage in achieving investment success for their clients. Within these research disciplines, they also have investment professionals that focus on multi-asset, wealth management and alternative investment strategies.

Details Hidden

JCM seeks to add value versus benchmarks by actively pursuing alpha generation through their own intensive fundamental research for their fundamental investment strategies. They look for companies possessing the firm’s key investment criteria through proprietary research that emphasizes contact with a company’s management team, competitors, suppliers and consumers, as well as in-depth and ongoing financial modeling. Holdings are generally selected one at a time with all other factors (industry, sector, country and cash allocations) being a residual of the investment process. JCM favors businesses that their research reveals have sustainable, above-average earnings growth potential and outstanding free cash flow generation, recurring revenue, profit margins and return on invested capital for their equity strategies. To build a mosaic of information in an effort to identify macro trends and inform allocations across fixed income sectors, the firm uses fundamental credit research.

Details Hidden

Renaissance Technologies LLC is an investment management company dedicated to producing superior returns for its clients and employees by adhering to mathematical and statistical methods.

Recent Transactions
Details Hidden

Vertex Pharmaceuticals, Inc. purchases Exonics Therapeutics, Inc. from The Column Group LLC, CureDuchenne Ventures LLC

Details Hidden

Vertex Pharmaceuticals, Inc. issued USD Common Stock

Details Hidden

Vertex Pharmaceuticals, Inc. purchases ViroChem Pharma, Inc.

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Underwriter

Advised onVertex Pharmaceuticals, Inc. issued USD Common Stock

Underwriter

Advised onVertex Pharmaceuticals, Inc. issued USD Common Stock

Underwriter

Advised onVertex Pharmaceuticals, Inc. issued USD Common Stock

Legal Advisor

Advised onVertex Pharmaceuticals, Inc. issued USD Common Stock

Professional

Advised onVertex Pharmaceuticals, Inc. issued USD Common Stock

Legal Advisor

Advised onVertex Pharmaceuticals, Inc. purchases ViroChem Pharma, Inc.

Advisors & Consultants
Advisor

Executive Vice Chair at Cushman & Wakefield of Massachusetts, Inc.

Advisor

Partner at Centerview Partners LLC

Advisor

Chief Financial Officer at Oxurion NV

Clients

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Walgreens Boots Alliance, Inc. engages in the provision of drug store services. It operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreens business, which includes the operation of retail drugstores, health and wellness services, and mail and central specialty pharmacy services. The Retail Pharmacy International segment consists of pharmacy-led health and beauty retail businesses and optical practices. The Pharmaceutical Wholesale segment consists of the Alliance Healthcare pharmaceutical wholesaling and distribution businesses and an equity method investment in AmerisourceBergen. The company was founded in 1901 and is headquartered in Deerfield, IL.

Cigna Corp. is a global health service company, which is dedicated to improving the health, well-being and peace of mind. Its products and services include an integrated suite of health services such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits and other related products including group life, accident and disability insurance.

Key Stats and Financials As of 2020
Market Capitalization
$54.7B
Total Enterprise Value
$56.5B
Earnings Per Share
$10.29
Revenue
$6.21B
Net Profit
$2.71B
EBITDA
$2.98B
EBITDAMargin
48.03%
Total Debt
$942M
Total Equity
$8.69B
Enterprise Value / Sales
9.1x
Enterprise Value EBITDAOperating
18.83x
TEVNet Income
20.85x
Debt TEV
0.02x
Three Year Compounded Annual Growth Rate Of Revenue
35.63%
Non-Profit Donations & Grants
$100K - $1M
2019
$5,000 - $10K
2018
$25K - $50K
2018
Investments
Details Hidden

Kymera Therapeutics, Inc. operates as a biotechnology company, which engages in curing untreatable diseases. It focuses on discovering and developing novel small molecule therapeutics. The firm's proprietary integrated degradation platform consists of informatics-driven target identification, novel E3 ligases and ligands, proprietary predictive modeling, and novel degradation tools. The company was founded by Bruce Lee Booth and Nello Mainolfi in September 2015 and is headquartered in Watertown, MA.

Details Hidden

Genomics Plc develops research and experimental development on biotechnology. It develops and applies cutting edge analysis and algorithms to database of genomic and phenotypic data to uncover the relationships between genetic variation and human disease. The company was founded by Peter Donnely, Gil McVean, Chris Spencer and Gerton Lunter on January 10, 2004 and is headquartered in Oxford, the United Kingdom.

Details Hidden

CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan and Craig Mellow in 2014 and is headquartered in Zug, Switzerland.

Suppliers
Diversified Healthcare Trust Trusts & Funds | Newton, MA

Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants. The SHOP segment manages senior living communities that offers short term and long term residential care, and other services for residents where it pay fees to the operator to manage the communities for its account. The company was founded on December 16, 1998 and is headquartered in Newton, MA.

CRISPR Therapeutics AG Medical Support Services | Zug, Che

CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan and Craig Mellow in 2014 and is headquartered in Zug, Switzerland.

Brooks Automation, Inc. Appliances & Electronics | Chemsford, MA

Brooks is a leading worldwide provider of automation, vacuum, and instrumentation solutions for multiple markets including semiconductor manufacturing, life sciences, and clean energy. Our technologies, engineering competencies, and breadth of global services provide customers speed to market, high uptime, and rapid response, which equate to superior value in their mission-critical environments. Since 1978, Brooks has been a leading partner to the global semiconductor manufacturing market. Through product development initiatives and strategic acquisition, we have expanded our reach to meet the needs of customers in the life sciences industry, analytical and research fields, and clean energy markets. When optimal productivity and high availability are factors for success, customers across the globe turn to Brooks. Brooks is a public company listed on the NASDAQ stock exchange under the symbol BRKS

Competitors
Bristol-Myers Squibb Company Pharmaceuticals - New York, New York

Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.

AbbVie, Inc. Pharmaceuticals - North Chicago, IL

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on 2013 and is headquartered in North Chicago, IL.

Novartis AG Pharmaceuticals - Basel, Switzerland

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Awards & Honors
Rank #11
2014
Forbes - World's 100 Most Innovative Companies
Sponsored by Forbes Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Vertex Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Vertex Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Vertex Pharmaceuticals, Inc..